Document is current

Article History

Received: 11 June 2024

Accepted: 25 February 2025

First Online: 1 April 2025

Declarations

:

: Conflicts of interest and financial disclosures: A.S.T. received speaker, advisory board and consultancy fees from Springer, Elsevier, Roche. S.B received speakers fees from Amgen. I.P. received speaker, advisory board and consultancy fees from SysMedical, Medtronic, Abbott, Edwards, Abiomed, Terumo, Philips, Sanofi, Amgen, Daiichi‐Sankyo, Astra Zeneca, Bayer, and Pfizer, and research grants from Chiesi, Bayer, Medtronic, and Abbott. C.M.: reports receiving honoraria for attending symposia, congresses and/or for speaking and/or consulting, and/or funds for research from Pfizer, Roche, Sobi, Novo Nordisk, Takeda, Philips, Canon and Esade.P.A. received speaker, advisory board and consultancy fees from Boehringer Ingelheim, Astra Zeneca, Bayer, Boehringer Ingelheim, Janssen, and MSD, and speaker and advisor fees and travel support from Daiichi Sankyo. Data sharing statement: Individual patient data and statistical analysis will be made available upon reasonable request to the corresponding author.

: The study received IRB approval and the need for informed consent was waived (370/2022 - DB id 12472).

: The study received IRB approval and the need for informed consent was waived (370/2022 - DB id 12472).

: All authors agreed with the content and that all gave explicit consent to submit.